![Kin Yip Leung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kin Yip Leung
Direktör/Styrelseledamot på
NOVOCURE LIMITED
Förmögenhet: 2 M $ per 2026-09-30
Profil
Kin Yip Leung is currently an Independent Director at NovoCure Ltd. since 2011.
Former roles include Independent Director at Curia Global, Inc. from 2010 to 2016; Director at Delcath Systems, Inc. in 2014; Director at NanoMed Pharmaceuticals, Inc.; Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2016 to 2019; Principal at Bristol Myers Squibb Co. from 1990 to 1999; EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. from 2003 to 2010; Group Vice President-Global Prescription Business at Pharmacia Corp.
from 1999 to 2003; and Member at C-Change.
Education includes undergraduate studies at The University of Texas at Austin and graduate studies at the University of Wisconsin.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NOVOCURE LTD. 0,09 % | 2026-06-03 | 101 109 ( 0,09 % ) | 2 M $ | 2026-09-30 |
Aktiva positioner av Kin Yip Leung
| Företag | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Direktör/Styrelseledamot | 2011-08-05 |
Tidigare kända positioner av Kin Yip Leung
| Företag | Position | Slut |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Direktör/Styrelseledamot | 2019-05-09 |
| ALBANY MOLECULAR RESEARCH, INC. | Direktör/Styrelseledamot | 2016-02-04 |
| DELCATH SYSTEMS, INC. | Ordförande | 2014-09-15 |
| OSI PHARMACEUTICALS, INC. | Företagsledare/Principal | 2010-01-01 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Företagsledare/Principal | 2003-04-01 |
Kin Yip Leungs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
80
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Curia Global, Inc.
 Curia Global, Inc. BiotechnologyHealth Technology Operates as a global contract research and manufacturing company that provides drug discovery, development & production services | Health Technology |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C-Change
 C-Change Other Consumer ServicesConsumer Services C-Change is a private company based in Washington, DC. C-Change was founded by Kevin Sharps, Lynn L. Davison. | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
